Xiaofang Yan
-
- Cancer-related molecular mechanisms research 3
- Cancer, Lipids, and Metabolism 2
- MicroRNA in disease regulation 2
-
- Effects and risks of endocrine disrupting chemicals 2
-
- Epigenetics and DNA Methylation 2
- Peroxisome Proliferator-Activated Receptors 2
-
- Trace Elements in Health 2
-
- Inflammatory mediators and NSAID effects 2
- Co-authors
- Maiying KongJiaqing HaoBing LiEdward R. SauterFeizhou JiangYuwen ZhangMostafa FraigYanwen Sun
- Partner nations
- ChinaUnited States
In The Last Decade
Xiaofang Yan
17 papers receiving 337 citations
Peers
Comparison fields: 5 of 60
- Cancer Research 140
- Health, Toxicology and Mutagenesis 41
- Molecular Biology 199
- Biochemistry 16
- Oncology 57
Countries citing papers authored by Xiaofang Yan
This map shows the geographic impact of Xiaofang Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofang Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofang Yan more than expected).
Fields of papers citing papers by Xiaofang Yan
This network shows the impact of papers produced by Xiaofang Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofang Yan. The network helps show where Xiaofang Yan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiaofang Yan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2021 | 7 | |
| 3 | 2021 | 13 | |
| 4 | 2020 | 2 | |
| 5 | 2020 | 8 | |
| 6 | 2019 | 44 | |
| 7 | 2019 | 8 | |
| 8 | 2018 | 114 | |
| 9 | 2018 | 20 | |
| 10 | 2017 | 6 | |
| 11 | 2017 | 8 | |
| 12 | ROR1 promotes the proliferation of endometrial cancer cells. | 2017 | 3 |
| 13 | 2016 | 46 | |
| 14 | 2015 | 44 | |
| 15 | 2014 | 14 | |
| 16 | [Use body fat determination instead of simple body composition parameters evaluate the risk of metabolic syndrome in Fuzhou adults]. | 2010 | 3 |
| 17 | 2008 | 1 |
About Xiaofang Yan
Xiaofang Yan is a scholar working on Applied Microbiology and Biotechnology, Cancer Research and Clinical Biochemistry, having authored 17 papers that have together received 342 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (3 papers), Effects and risks of endocrine disrupting chemicals (2 papers), Trace Elements in Health (2 papers), Epigenetics and DNA Methylation (2 papers), Cancer, Lipids, and Metabolism (2 papers), MicroRNA in disease regulation (2 papers), Peroxisome Proliferator-Activated Receptors (2 papers) and Inflammatory mediators and NSAID effects (2 papers). The work is most often cited by research in Cancer Research (140 citations), Health, Toxicology and Mutagenesis (41 citations) and Molecular Biology (199 citations). Xiaofang Yan has collaborated with scholars based in China and United States. Frequent co-authors include Maiying Kong, Jiaqing Hao, Bing Li, Edward R. Sauter, Feizhou Jiang, Yuwen Zhang, Mostafa Fraig, Yanwen Sun, Jun Zeng and Sabine Waigel. Their work appears in journals such as Cell Metabolism, Scientific Reports and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.